Suresh Agarwal - Concepedia

Author

Suresh Agarwal

Also Known As

Agarwal, Suresh Kumar, Gonzalez-Guarda, Rosa, S Agarwal, S. Agarwal, S. K. Agarwal, S.K. Agarwal, SURESH K. AGARWAL, Suresh Agarwal, Suresh Agarwal ., Suresh Agarwal,

283

Publications

7.6K

Citations

H-Index

195

Concepts

All Affiliations

AbbVie (United States)University of Wisconsin–Madison Duke Medical Center Ain Shams University Duke University

About

Suresh Agarwal is an author at AbbVie (United States) specializing in medicine, emergency medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	11	12	1.3K
2	Education	4	4	75
3	Engineering	3	3	53
4	Arts	1	1	12
5	Management	1	1	35

Suresh Agarwal

100

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Courtney D. DiNardo, Keith W. Pratz, Anthony Letai, The Lancet Oncology Hematological MalignancyOncologyElderly PatientsMixed-phenotype Acute LeukemiaHematology	2018	692
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study Andrew H. Wei, Stephen A. Strickland, Jing-Zhou Hou, Journal of Clinical Oncology	2019	680
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma Shaji Kumar, Jonathan L. Kaufman, Cristina Gasparetto, Blood	2017	517
Emergency general surgery Shahid Shafi, Michel B. Aboutanos, Suresh Agarwal, The Journal of Trauma: Injury, Infection, and Critical Care	2013	344
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study John F. Seymour, Shuo Ma, Danielle M. Brander, The Lancet Oncology Phase 1BLymphoid NeoplasiaHematological MalignancyMedicineImmunology	2017	321
Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments Suresh Agarwal, Courtney D. DiNardo, Jalaja Potluri, Clinical Therapeutics Venetoclax-posaconazole InteractionDose AdjustmentsHematological MalignancyOncologyHealth Sciences	2017	225
The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients Ishaq Lat, Wes McMillian, Scott Taylor, Critical Care Medicine	2009	220
Safety and efficacy of ERCP in pregnancy Michel Kahaleh, Gary D. Hartwell, Kristen O. Arseneau, Gastrointestinal Endoscopy FertilityMaternal Cardiovascular OutcomeGynecologyPregnancyMaternal Health	2004	170
The American Association for the Surgery of Trauma grading scale for 16 emergency general surgery conditions Gail T. Tominaga, Kristan Staudenmayer, Shahid Shafi, The Journal of Trauma: Injury, Infection, and Critical Care Trauma ResuscitationAmerican AssociationTraumatologyTrauma CommitteeSurgery	2016	137
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy Steven Coutré, Michael Y. Choi, Richard R. Furman, Blood	2018	131

Page 1